[{"id":"3bea20a1-a979-4959-b4e2-6a88db539ae8","acronym":"","url":"https://clinicaltrials.gov/study/NCT00446082","created_at":"2021-01-18T01:34:38.995Z","updated_at":"2024-07-02T16:36:37.050Z","phase":"Phase 1","brief_title":"Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease","source_id_and_acronym":"NCT00446082","lead_sponsor":"Novartis Pharmaceuticals","biomarkers":" IGF1 • CHGA","pipe":" | ","alterations":" IGF1 elevation","tags":["IGF1 • CHGA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IGF1 elevation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Signifor LAR (pasireotide long acting release)"],"overall_status":"Completed","enrollment":" Enrollment 85","initiation":"Initiation: 06/01/2006","start_date":" 06/01/2006","primary_txt":" Primary completion: 11/01/2013","primary_completion_date":" 11/01/2013","study_txt":" Completion: 11/01/2013","study_completion_date":" 11/01/2013","last_update_posted":"2020-12-21"}]